Delivery Order SPE2DB20D2104-SPE2DB22FR55K
- Not listed
- This federal contract award, valued at $1,212.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,557,309 units of Lisinopril 40 mg tablets. It is a firm-fixed-price delivery order contract with a completion date of February 6, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, valued at $9,085.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of 4,565,079,360 tablets of Lisinopril 10 mg, a common cardiovascular medication. The contract has an ultimate completion date of July 8, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $2,487.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the drug Lisinopril, a cardiovascular medication, with a completion date of November 19, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This federal contract award, with a value of $12,344.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,605,288 Lisinopril 10 mg tablets, a common blood pressure medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 15, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-25 mg. The single-award, firm-fixed price delivery order, valued at $2,066.47, has a completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,110,689 lisinopril 20 mg tablets in lots of 1,000. This $1,056.28 award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract with DLA to deliver pharmaceutical products and medical...
- This federal contract award, valued at $1,243.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,701,371 units of Lisinopril 20 mg tablets, a cardiovascular medication, with an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,556 units of Lisinopril-HCTZ 20-12.5 mg tablets in 1,000 count bottles. The $1,418.22 firm-fixed price delivery order has an ultimate completion date of August 26, 2024. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for supplying a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,654.66, is a delivery order for 4,563,436,091 tablets of the generic drug Lisinopril 10 mg. The award has an ultimate completion date of January 25, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Lisinopril 40 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for a firm fixed price of $2,423.08. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR55KDelivery Order
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $6,524.03 delivery order contract is for the supply of Lisinopril 20 mg tablets, a cardiovascular medication. The contract has a period of performance through January 20, 2022 and utilizes a firm fixed price pricing structure. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract demonstrates Amerisourcebergen's role as a critical pharmaceutical distributor for the U.S. federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 1/19/22 |